KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Deferred Taxes (2016 - 2025)

Astrana Health's Deferred Taxes history spans 12 years, with the latest figure at -$3.0 million for Q3 2025.

  • For Q3 2025, Deferred Taxes fell 779.23% year-over-year to -$3.0 million; the TTM value through Sep 2025 reached -$1.6 million, up 90.21%, while the annual FY2024 figure was -$4.2 million, 65.86% up from the prior year.
  • Deferred Taxes for Q3 2025 was -$3.0 million at Astrana Health, down from -$1.6 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $11.2 million in Q2 2021 and bottomed at -$11.2 million in Q4 2022.
  • The 5-year median for Deferred Taxes is -$358000.0 (2025), against an average of -$1.5 million.
  • The largest annual shift saw Deferred Taxes skyrocketed 538.0% in 2021 before it crashed 14472.73% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at $824000.0 in 2021, then tumbled by 1462.14% to -$11.2 million in 2022, then increased by 24.2% to -$8.5 million in 2023, then soared by 139.34% to $3.3 million in 2024, then tumbled by 188.53% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Deferred Taxes are -$3.0 million (Q3 2025), -$1.6 million (Q2 2025), and -$358000.0 (Q1 2025).